Center for Vascular and Inflammatory Diseases, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America.
PLoS One. 2011;6(12):e28846. doi: 10.1371/journal.pone.0028846. Epub 2011 Dec 9.
Vascular remodeling in response to alterations in blood flow has been shown to modulate the formation of neo-intima. This process results from a proliferative response of vascular smooth muscle cells and is influenced by macrophages, which potentiate the development of the intima. The LDL receptor-related protein 1 (LRP1) is a large endocytic and signaling receptor that recognizes a number of ligands including apoE-containing lipoproteins, proteases and protease-inhibitor complexes. Macrophage LRP1 is known to influence the development of atherosclerosis, but its role in vascular remodeling has not been investigated.
METHODOLOGY/PRINCIPAL FINDINGS: To define the contribution of macrophage LRP1 to vascular remodeling, we generated macrophage specific LRP1-deficient mice (macLRP1-/-) on an LDL receptor (LDLr) knock-out background. Using a carotid ligation model, we detected a 2-fold increase in neointimal thickening and a 2-fold increase in the intima/media ratio in macLRP1-/- mice. Quantitative RT-PCR arrays of the remodeled vessel wall identified increases in mRNA levels of the TGF-β2 gene as well as the Pdgfa gene in macLRP1-/- mice which could account for the alterations in vascular remodeling. Immunohistochemistry analysis revealed increased activation of the TGF-β signaling pathway in macLRP1-/- mice. Further, we observed that LRP1 binds TGF-β2 and macrophages lacking LRP1 accumulate twice as much TGF-β2 in conditioned media. Finally, TNF-α modulation of the TGF-β2 gene in macrophages is attenuated when LRP1 is expressed. Together, the data reveal that LRP1 modulates both the expression and protein levels of TGF-β2 in macrophages.
CONCLUSIONS/SIGNIFICANCE: Our data demonstrate that macrophage LRP1 protects the vasculature by limiting remodeling events associated with flow. This appears to occur by the ability of macrophage LRP1 to reduce TGF-β2 protein levels and to attenuate expression of the TGF-β2 gene resulting in suppression of the TGF-β signaling pathway.
血流变化引起的血管重塑已被证明能调节新生内膜的形成。这一过程源于血管平滑肌细胞的增殖反应,并受到巨噬细胞的影响,巨噬细胞促进了内膜的发展。低密度脂蛋白受体相关蛋白 1(LRP1)是一种大型内吞和信号受体,可识别包括载脂蛋白 E 在内的脂蛋白、蛋白酶和蛋白酶抑制剂复合物等多种配体。已知巨噬细胞 LRP1 影响动脉粥样硬化的发展,但它在血管重塑中的作用尚未被研究。
方法/主要发现:为了确定巨噬细胞 LRP1 对血管重塑的贡献,我们在 LDL 受体(LDLr)敲除背景下生成了巨噬细胞特异性 LRP1 缺陷小鼠(macLRP1-/-)。通过颈动脉结扎模型,我们检测到 macLRP1-/-小鼠的新生内膜增厚增加了 2 倍,内膜/中膜比增加了 2 倍。对重塑血管壁的定量 RT-PCR 阵列分析表明,macLRP1-/-小鼠的 TGF-β2 基因和 Pdgfa 基因的 mRNA 水平增加,这可能解释了血管重塑的改变。免疫组织化学分析显示,macLRP1-/-小鼠中 TGF-β 信号通路的激活增加。此外,我们观察到 LRP1 结合 TGF-β2,缺乏 LRP1 的巨噬细胞在条件培养基中积累的 TGF-β2 增加了两倍。最后,当 LRP1 表达时,TNF-α对巨噬细胞中 TGF-β2 基因的调节作用减弱。总之,这些数据表明 LRP1 调节巨噬细胞中 TGF-β2 的表达和蛋白水平。
结论/意义:我们的数据表明,巨噬细胞 LRP1 通过限制与血流相关的重塑事件来保护血管。这似乎是通过巨噬细胞 LRP1 降低 TGF-β2 蛋白水平和减弱 TGF-β2 基因的表达来实现的,从而抑制 TGF-β 信号通路。